Clinical Trials

Nanoparticle 'Super Adjuvant' Vaccine Blocks Multiple Cancers in Mice

The peer-reviewed mouse study introduces a dual-adjuvant lipid nanoparticle platform now headed toward translation through a new startup, with human testing yet to begin.